Veterinary World


ISSN (Online): 2231-0916


 Editorial board

 Instructions for authors

 Reviewer guideline

 Open access policy




Open Access

Copyright: The authors. This article is an open access article licensed under the terms of the Creative Commons Attribution License ( which permits unrestricted use, distribution and reproduction in any medium, provided the work is properly cited.

Research (Published online : 01-12-2013)

1. Effect of meloxicam and its combination with levofloxacin, pazufloxacin, and enrofloxacin on the plasma antioxidative activity and the body weight of rabbits - Adil Mehraj Khan and Satyavan Rampal
Veterinary World, 6(12): 950-954


doi: 10.14202/vetworld.2013.950-954


1. Gunes, V., Cinar, M., Onmaz, A. C., Atalan, G. and Yavuz, U. (2011) Effects of Meloxicam on oxidative deterioration due to exercise in horses. Revue. Med. Vet., 162: 258-264.
2. Blondeau, J. M. (1999) Expanded activity and utility of the new fluoroquinolones: a review. Clin. Ther., 21: 3-40.
3. Martinez, M., McDermott, P. and Walker, R. (2006) Pharmacology of the fluoroquinolones: a perspective for the use in domestic animals. Vet. J., 172: 10-28.
4. Fernandez, J., Barrett, J. F., Licata, L., Amaratunga, D. and Frosco, M. (1999) Comparison of efficacies of oral levofloxacin and oral ciprofloxacin in a rabbit model of a staphylococcal abscess. Antimicrob. Agents. Chemother., 43(3): 667.
PMid:10049285 PMCid:PMC89178
5. Zhanel, G. G., Fontaine, S., Adam, H., Schurek, K., Mayer, M., Noreddin, A. M., Gin, A. S., Rubinstein, E. and Hoban, D. J. (2006) A review of new fluoroquinolones: focus on their use in respiratory tract infections. Treat. Respir. Med., 5: 437- 465.
6. Vora, A. (2009) Pazufloxacin. J. Assoc. Physicians. India., 57.
7. Mitchell, M. A. (2006) Enrofloxacin. J. Exot. Pet. Med., 15(1): 66-69.
8. Zhao, B., Chingnell, C. F., Rammal, M., Smith, F., Hamilton, M. G., Andley, U. P. and Roberts, J. E. (2010) Detection and prevention of ocular phototoxicity of ciprofloxacin and other fluoroquinolone antibiotics. Photochem. Photobiol., 86(4): 798-805.
PMid:20528972 PMCid:PMC2910230
9. Levofloxacin, Wikipedia, Levofloxacin (Acessed on 20 September 2013).
10. Schmidt, U. and Schlüter, G. (1996) Studies on the mechanism of phototoxicity of Bay y3118 and other quinolones. Adv. Exp. Med. Biol., 387: 117-120.
11. Thuong-Guyot, M., Domale, O., Pocidalo, J. J. and Hayem, G. (1994) Effects of flouroquinolones on cultured articular condrocytes flow cytometric analysis of free radical production. J. Pharmacol. Exp. Ther., 271: 1544-1549.
12. Yazar, E. and Tras, B. (2001) Effects of fluoroquinolone antibiotics on hepatic superoxide dismutase and glutathione peroxidase activities in healthy and experimentally induced peritonitis mice. Revue. Med. Vet., 152(3): 235-238.
13. Ozgocmen, S., Ardicoglu, O., Erdogan, H., Fadillioglu, E. and Gudul, H. (2005) In vivo effect of celecoxib and tenoxicam on oxidant/anti-oxidant status of patients with knee osteoarthritis. Ann. Clin. Lab. Sci., 35: 137-143.
14. Edfawy, M., Hassan, M. H., Mansour, A., Hamed, A. A. and Amin, H. A. (2012) Meloxicam modulates oxidative stress status, inhibits prostaglandin E2, and abrogates apoptosis in carbon tetrachloride-induced rat hepatic injury. Int. J. Toxicol., 31(3): 276-286.
15. Burak Cimen, M. Y., Cimen, O. B., Eskandari, G., Sahin, G., Erdogan, C. and Atik, U. (2003) In vivo effects of meloxicam, celecoxib, and ibuprofen on free radical metabolism in human erythrocytes. Drug. Chem. Toxicol., 26(3): 169-176.
16. Villegas, I., Martin, M. J., La Casa, C., Motilva, V. and De La Lastra, C. A. (2002) Effects of oxicam inhibitors of cyclooxygenase on oxidative stress generation in rat gastric mucosa. a comparative study. Free. Radic. Res., 36(7): 769- 777.
17. Li, H., Hortmann, M., Daiber, A., Oelze, M., Ostad, M. A., Schwarz, P. M., Xu, H., Xia, N., Kleschyov, A. L., Mang, C., Warnholtz, A., Munzel, T. and Forstermann, U. (2008) Cyclooxygenase 2-selective and nonselective nonsteroidal anti-inflammatory drugs induce oxidative stress by up- regulating vascular NADPH oxidases. J. Pharmacol. Exp. Ther., 326(3): 745-753.
18. Suresh, D. R., Annam, V., Pratibha, K. and Prasad, B. V. (2009) Total antioxidant capacity–a novel early bio- chemical marker of oxidative stress in HIV infected individuals. J. Biomed. Sci., 16: 61.
PMid:19583866 PMCid:PMC2714592
19. Nagy, G., Ward, J., Mosser, D. D., Koncz, A., Gergely, P. Jr., Stancato, C., Qian, Y., Fernandez, D., Niland, B., Grossman, C. E., Telarico, T., Banki, K. and Perl, A. (2006) Regulation of CD4 expression via recycling by HRES-1/RAB4 controls susceptibility to HIV infection. J. Biol. Chem., 281(45): 34574-34591.
20. Motoyama, T., Okamoto, K., Kukita, I., Hamaguchi, M., Kinoshita, Y. and Ogawa, H. (2003) Possible role of increased oxidant stress in multiple. Care. Med., 31: 1048- 1052.
21. Lipsky, B. A., Byren, I. and Hoey, C. T. (2010) Treatment of Bacterial Prostatitis. Clin. Infect. Dis., 50(12): 1641-1652.
22. Wagenlehner, F. M. E. and Krieger, J. N. (2011) Treatment of chronic bacterial prostatitis. Pelviperineol., 30: 17-26.
23. Gadde, K. M., Franciscy, D. M., Wagner, H. R. and Krishnan, K. R. (2003) Zonisamide for weight loss in obese adults: a randomized controlled trial. J. Am. Med. Assoc., 289(14): 1820-1825.
24. Sicras-Mainar, A., Navarro-Artieda, R., Rejas-Gutiérrez, J. and Blanca-Tamayo M. (2008) Relationship between obesity and antipsychotic drug use in the adult population: A longitudinal, retrospective claim database study in Primary Care settings. Neuropsychiatr. Dis. Treat., 4(1): 219-226. 25. Croisier, D., Chavanet, P., Lequeu, C., Ahanou, A., Nierlich, A., Neuwirth, C., Piroth L., Duong, M., Buisson, M. and Portier, H. (2002) Efficacy and pharmacodynamics of simulated human-like treatment with levofloxacin on experimental pneumonia induced with penicillin-resistant pneumococci with various susceptibilities to fluoroquino- lones. J. Antimicrob. Chemother., 50(3): 349-360.
26. Mayer, J. (2007) Analgesia and anesthesia in rabbits and rodents. Proceedings: Western Veterinary Conference.
27. Adamcak, A. and Otten, B. (2000) Rodent Therapeutics. Vet. Clin. N.Am: Exotic. Anim. Pract. 3: 221-240.
28. Koracevic, D., Koracevic, G., Djordjevic, V., Andrejevic, S. and Cosic, V. (2001) Method for the measurement of antioxidant activity in human fluids. J. Clin. Pathol., 54: 356-361.
PMid:11328833 PMCid:PMC1731414
29. Duncan, D. B. (1995) Multiple range and multiple F-tests. Biometrics., 11: 1-14.
30. Rampal, S., Kaur, R., Sethi, R., Singh, O. and Sood, N. (2008) Ofloxacin-associated retinopathy in rabbits: role of oxidative stress. Human. Exp. Toxicol., 27: 409-415.
31. Li, Q., Peng, S., Sheng, Z. and Wang, Y. (2010) Ofloxacin induces oxidative damage to joint chondrocytes of juvenile rabbits: excessive production of reactive oxygen species, lipid peroxidation and DNA damage. Eur. J. Pharmacol., 25:626(2-3): 146-153.
32. Talla, V. and Veerareddy, P. R. (2011) Oxidative stress induced by fluoroquinolones on treatment for complicated urinary tract infections in Indian patients. J. Young. Pharm., 3: 304-309.
PMid:22224037 PMCid:PMC3249743
33. Arafa, N. M., Abdel-Rahman, M., El-khadragy, M. F. and Kassab, R. B. (2013) Evaluation of the possible epilepto- genic activity of ciprofloxacin: the role of Nigella sativa on amino acids neurotransmitters. Neurochem. Res., 38(1): 174- 185.
34. Araniciu, C., Parvu, A. E., Tiperciuc, B., Palage, M., Oniga, S., Verite P. and Oniga, O. (2013) Synthesis and evaluation of the anti-inflammatory activity of some 2-(trimetho- xyphenyl)-4-r1-5-r2-thiazoles. Dig. J. Nanomatr. Bios., 8(2): 699-709.
35. Kovacic, P, Pozos, R. S., Somanathan, R., Shangari, N. and O'Brien, P. J. (2005) Mechanism of mitochondrial uncouplers, inhibitors, and toxins: Focus on electron transfer, free radicals, and structure–activity relationships. Curr. Med. Chem., 12: 2601-2623.
36. Valko, M., Leibfritz, D., Moncola. J., Cronin, M. T. D., Mazura, M. and Telser, J. (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell. Biol., 39: 44-84.
37. Berzosa, C., Cebrian, I., Fuentes-Broto, L., Gomez-Trullen, E., Piedrafita, E., Martinez-Ballarin, E., Lopez-Pingarron, L., Reiter, R. J. and Garcia, J. J. (2011) Acute exercise increases plasma total antioxidant status and antioxidant enzyme activities in untrained men. J. Biomed. Biotechnol., 540458.
PMid:21436993 PMCid:PMC3062968
38. Kaur, S., Verma, I., Narang, A. P. S., Chinna, R. S., Singh, P. and Aggarwal, S. P. (2011) Assessment of total antioxidant status in acute pancreatitis and prognostic significance. Int. J. Biol. Med. Res., 2(2): 575-576.
39. Ghiselli, A., Serafini, M., Natella, F. and Scaccini, C. (2000) Total antioxidant capacity as a tool to assess redox status: critical view and experimental data. Free. Radic. Biol. Med., 29(11): 1106-1114.
40. Ristow, M. and Schmeisser, S. (2011) Extending life span by increasing oxidative stress. Free. Rad. Biol. Med., 51: 327- 336.
41. Mytilineou, C., Kramer, B. C. and Yabut, J. A. (2002) Glutathione depletion and oxidative stress. Parkinsonism. Relat. Disord., 8: 385-387.
42. Dubey, N., Khan, A.M. and Raina, R. (2013) Sub-acute deltamethrin and fluoride toxicity induced hepatic oxidative stress and biochemical alterations in rats. Bull. Environ. Contam. Toxicol., 91: 334-338.
43. Khan, A. M., Dubey, N., Raina, R., Singh, G. and Beigh, S. A. (2013) Toxic effects of deltamethrin and fluoride on hematological parameters in rats. Fluoride., 46(1): 34-38.
44. Khan, A. M., Sultana, M., Raina, R., Dubey, N. and Dar, S. A. (2013) Effect of sub-acute toxicity of bifenthrin on antioxidant status and hematology after its oral exposure in goats. Proc. Natl. Acad. Sci. India. Sect B. Biol. Sci., 83(4): 545-549.
45. Dar, M. A., Khan, A. M., Raina, R., Verma, P. K. and Sultana, M. (2013) Effect of repeated oral administration of bifenthrin on lipid peroxidation and anti-oxidant parameters in Wistar rats. Bull. Environ. Contam. Toxicol., 91: 125-128.